
PAVmed PAVM
$ 1.3
-13.91%
Country |
|
IPO year |
2016 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
670 K |
Market Cap[1] |
$ 872 K |
EBITDA (LTM) |
$ -28.6 M |
P/E (LTM) |
-0.176034 |
P/S (LTM) |
7.520095 |
EPS (LTM) |
-9.43 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AVITA Medical
RCEL
|
$ 16.71 | 5.96 % | $ 466 M | Nasdaq Global Select Market | ||
|
Sintx Technologies
SINT
|
$ 1.21 | -2.42 % | $ 3.36 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Beyond Air
XAIR
|
$ 1.84 | -8.46 % | $ 15.3 B | Nasdaq Global Select Market | ||
|
Xtant Medical Holdings
XTNT
|
$ 0.21 | 3.74 % | $ 29.3 M | NYSE American | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Vivos Therapeutics
VVOS
|
$ 0.08 | -5.9 % | $ 822 K | Nasdaq Global Select Market | ||
|
Varex Imaging Corporation
VREX
|
$ 18.14 | 0.19 % | $ 751 M | Nasdaq Global Select Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 7.38 | -2.06 % | $ 997 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 58.04 | -2.31 % | $ 1.7 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 126.97 | -0.01 % | $ 4.41 B | NYSE,SPB | ||
|
Avanos Medical
AVNS
|
$ 24.99 | - | $ 1.16 B | NYSE,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.62 | -0.92 % | $ 35.7 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
- | - | $ 140 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Ra Medical Systems
RMED
|
- | 10.0 % | $ 610 K | NYSE American | ||
|
ReWalk Robotics Ltd.
RWLK
|
- | 7.07 % | $ 66.1 M | Nasdaq Global Select Market | ||
|
STRATA Skin Sciences
SSKN
|
- | - | $ 6.6 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
ShockWave Medical
SWAV
|
- | - | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 105.14 | -0.28 % | $ 61.5 B | NYSE,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
ThermoGenesis Holdings
THMO
|
- | -25.84 % | $ 171 K | Nasdaq Global Select Market | ||
|
Talis Biomedical Corporation
TLIS
|
- | 3.55 % | $ 7.96 M | Nasdaq Global Select Market | ||
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Titan Medical
TMDI
|
- | -26.32 % | $ 19.6 M | Nasdaq Global Select Market | ||
|
SmileDirectClub
SDC
|
- | -53.45 % | $ 9.71 M | Nasdaq Global Select Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Sientra
SIEN
|
- | -16.59 % | $ 10.3 M | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Smith & Nephew plc
SNN
|
$ 30.34 | -0.57 % | $ 26.3 B | NYSE | ||
|
Viveve Medical
VIVE
|
- | -15.35 % | $ 1.71 M | Nasdaq Global Select Market | ||
|
Penumbra
PEN
|
$ 320.36 | 0.39 % | $ 12.5 B | NYSE,SPB | ||
|
Venus Concept
VERO
|
- | - | $ 726 K | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.